AB 2960: Sexually transmitted diseases: testing.
- Session Year: 2023-2024
- House: Assembly
- Latest Version Date: 2024-04-29
Current Status:
Failed
(2024-05-16: In committee: Held under submission.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
Existing law provides for the licensure and regulation of health facilities, including primary care clinics and general acute care hospitals, by the State Department of Public Health. A violation of these provisions is a crime. Existing law requires the State Department of Health Care Services to investigate conditions affecting the prevention and control of venereal diseases, as defined, and approved procedures for prevention and control, and to disseminate educational information relating to venereal disease. Existing law requires the department to cooperate with specified entities, including clinics and public and private hospitals, to prevent, control and cure venereal diseases, including syphilis.
Existing law requires every licensed physician and surgeon or other person engaged in prenatal care of a pregnant woman, or attending the woman at the time of delivery, to obtain or cause to be obtained a blood specimen of the woman to test for syphilis.This bill would would, until January 1, 2030, require a licensed primary care clinic or hospital emergency department to offer a syphilis test at least once a year to all patients who can become pregnant. who are sexually active and at least 15 years of age and authorize a licensed primary care clinic or hospital emergency room to offer the test to a patient under 15 years of age, as specified. The bill would exempt the patients primary care clinic from these provisions if the patient has been tested, or if they have been offered the test and declined it in the past 12 months. The bill would specifically provide that a primary care clinic or hospital emergency department is not prohibited from charging a patient to cover the cost of the test. The bill would also state the intent of the Legislature to first offer bicillin, the preferred treatment for pregnant persons with syphilis, to those who are pregnant in the case of a shortage of the medication. The bill would exempt a violation of these provisions from being a crime.
Existing law provides for the licensure and regulation of clinics, health facilities, including primary care clinics, clinics and general acute care hospitals, by the State Department of Public Health. A violation of these provisions is a crime. Existing law requires the State Department of Health Care Services to investigate conditions affecting the prevention and control of venereal diseases, as defined, and approved procedures for prevention and control, and to disseminate educational information relating to venereal disease. Existing law requires the department to cooperate with specified entities, including clinics, clinics and public and private hospitals, to prevent, control and cure venereal diseases, including syphilis.
Existing law requires every licensed physician and surgeon or other person engaged in prenatal care of a pregnant woman, or attending the woman at the time of delivery, to obtain or cause to be obtained a blood specimen of the woman to test for syphilis.
This bill would require a licensed primary care clinic or hospital emergency department to offer a syphilis test at least once a year to all female patients between 15 and 44 years of age at least once per year. who can become pregnant. The bill would exempt the patients primary care clinic from these provisions if the patient has been tested, or if they have been offered the test and declined it in the past 12 months. The bill would specifically provide that a primary care clinic or hospital emergency department is not prohibited from charging a patient to cover the cost of the test. The bill would also state the intent of the Legislature to first offer bicillin, the preferred treatment for pregnant persons with syphilis, to those who are pregnant in the case of a shortage of the medication. The bill would exempt a violation of these provisions from being a crime.
Existing law provides for the licensure and regulation of clinics, including primary care clinics, by the State Department of Public Health. A violation of these provisions is a crime. Existing law requires the State Department of Health Care Services to investigate conditions affecting the prevention and control of venereal diseases, as defined, and approved procedures for prevention and control, and to disseminate educational information relating to venereal disease. Existing law requires the department to cooperate with specified entities, including clinics, to prevent, control and cure venereal diseases, including syphilis.
Existing law requires every licensed physician and surgeon or other person engaged in prenatal care of a pregnant woman, or attending the woman at the time of delivery, to obtain or cause to be obtained a blood specimen of the woman to test for syphilis.
This bill would require a licensed primary care clinic to offer a syphilis test to all female patients between 15 and 44 years of age at least once per year. The bill would exempt a violation of these provisions from being a crime.
The Legislature finds and declares all of the following:
(a)The epidemic of sexually transmitted infections in California has been growing since 2000.
(b)The most alarming increase has been in the number of all syphilis cases, rising 287 percent in the last 10 years of published data reported by the State Department of Public Health (CDPH). Health.
(c)The impact of syphilis among females has been even greater, increasing 1,113 percent over the same period.
(d)Particularly tragic is that the persistence of syphilis infections among women in their reproductive years has led to a meteoric rise in congenital syphilis, when the infection is transmitted from the mother to the child during pregnancy. Cases of congenital syphilis increased by 1,500 percent during the last 10 years, leading to hundreds of stillbirths, neonatal deaths, and other symptoms and complications.
(e)According to the United States Centers for Disease Control and Prevention (CDC), Prevention, California has the 11th highest rate of congenital syphilis in the nation, which is 63 percent higher than the national average.
(f)Under existing law, health care providers are required to test a pregnant woman for syphilis at least twice: early in the pregnancy and during the third trimester. However, March of Dimes reports that 15 percent of pregnant persons in California received no or inadequate prenatal care, and the CDC reports that even with timely testing and treatment, 12 percent of congenital syphilis cases still lead to death or other health complications. (g)The CDPH states that a priority target for syphilis testing and treatment are people who can become pregnant and who face obstacles in obtaining health care.(h)The CDC recommends screening asymptomatic women who are at increased risk for syphilis infection. (i)The United States Preventive Services Task Force found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides a substantial benefit. (j)The Los Angeles County Department of Public Health states, Since more than half of all pregnancies in [Los Angeles County] are unplanned, prevention, detection, and treatment of syphilis in women of reproductive age is important to eliminate congenital syphilis. All women of child-bearing age (15-44 years) should be tested for syphilis at least once. (k)Routine syphilis testing provides an opportunity to educate people about syphilis, expand awareness among the general public about the adverse impacts of syphilis infection, and identify and treat any existing infections before a person becomes pregnant. (l)Requiring providers on the front lines of health care services to offer a syphilis test is one known productive route to curb the persistent infection rates.(m)The United States is currently experiencing a shortage of bicillin, the most effective treatment for congenital syphilis. The CDC and the CDPH are recommending that in the event of a bicillin shortage, medical providers should reserve bicillin for persons who are pregnant and that doxycycline should be the alternative treatment for syphilis in persons who are not pregnant.SEC. 2.Section 1216.5 is added to the Health and Safety Code, to read:1216.5.(a)At least once per year, a primary care clinic licensed under Section 1204 or a hospital emergency department shall offer a syphilis test to all patients who can become pregnant. test, as outlined in the most recent guidelines published by the Centers for Disease Control and Prevention, to all patients who are sexually active and at least 15 years of age. A primary care clinic or hospital emergency department may offer a syphilis test to a patient under 15 years of age as permitted under Section 6926 of the Family Code. This subdivision shall not apply to a primary care clinic if the patients primary care clinic has tested the patient for syphilis or if the patient has been offered a syphilis test and declined the test within the previous 12 months.
(b)This section shall not prohibit a primary care clinic or emergency department from charging a patient to cover the cost of syphilis testing. The primary care clinic or emergency department shall be deemed to have complied with this section if a syphilis test is offered.
(c)It is the intent of the Legislature that if there is a shortage of bicillin, the preferred treatment for pregnant persons with syphilis, bicillin should be provided first to persons who are pregnant.(d)(c)A violation of this section shall not constitute a crime pursuant to Section 1235.
(d)This section shall become inoperative on January 1, 2030.
The Legislature finds and declares all of the following:
(a)The epidemic of sexually transmitted infections in California has been growing since 2000.
(b)The most alarming increase has been in the number of all syphilis cases, rising 287 percent in the last 10 years of published data reported by the State Department of Public Health. Health (CDPH).
(c)The impact of syphilis among females has been even greater, increasing 1,113 percent over the same period.
(d)Particularly tragic is that the persistence of syphilis infections among women in their reproductive years has led to a meteoric rise in congenital syphilis, when the infection is transmitted from the mother to the child during pregnancy. Cases of congenital syphilis increased by 1,500 percent during the last 10 years, leading to hundreds of stillbirths, neonatal deaths, and other symptoms and complications.
(e)According to the United States Centers for Disease Control and Prevention (CDC), California has the 11th highest rate of congenital syphilis in the nation. nation, which is 63 percent higher than the national average.
(f)Under existing law, health care providers are required to test a pregnant woman for syphilis at least twice: early in the pregnancy and during the third trimester. However, March of Dimes reports that 15 percent of pregnant persons in California received no or inadequate prenatal care, and the CDC reports that even with timely testing and treatment, 12 percent of congenital syphilis cases still lead to death or other health complications.
(g)The State Department of Public Health CDPH states that a priority target for syphilis testing and treatment are people who can become pregnant and who face obstacles in obtaining healthcare. health care.
(h)The CDC recommends screening asymptomatic women who are at increased risk for syphilis infection.
(i)The United States Preventive Services Task Force found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides a substantial benefit.
(j)The Los Angeles County Department of Public Health states, Since more than half of all pregnancies in [Los Angeles County] are unplanned, prevention, detection, and treatment of syphilis in women of reproductive age is important to eliminate congenital syphilis. All women of child-bearing age (15-44 years) should be tested for syphilis at least once.
(k)Routine syphilis testing provides an opportunity to educate people about syphilis, expand awareness among the general public about the adverse impacts of syphilis infection, and identify and treat any existing infections before a person becomes pregnant.
(l)Requiring providers on the front lines of health care services to offer a syphilis test is one known productive route to curb the persistent infection rates.
(m)The United States is currently experiencing a shortage of bicillin, the most effective treatment for congenital syphilis. The CDC and the CDPH are recommending that in the event of a bicillin shortage, medical providers should reserve bicillin for persons who are pregnant and that doxycycline should be the alternative treatment for syphilis in persons who are not pregnant.
SEC. 2.Section 1216.5 is added to the Health and Safety Code, to read:1216.5.(a)A At least once per year, a primary care clinic licensed under Section 1204 or a hospital emergency department shall offer a syphilis test to all female patients between 15 and 44 years of age at least once per year. patients who can become pregnant. This subdivision shall not apply to a primary care clinic if the patients primary care clinic has tested the patient for syphilis or if the patient has been offered a syphilis test and declined the test within the previous 12 months.
(b)This section shall not prohibit a primary care clinic or emergency department from charging a patient to cover the cost of syphilis testing. The primary care clinic or emergency department shall be deemed to have complied with this section if a syphilis test is offered.
(c)It is the intent of the Legislature that if there is a shortage of bicillin, the preferred treatment for pregnant persons with syphilis, bicillin should be provided first to persons who are pregnant.
(b)(d)A violation of this section shall not constitute a crime pursuant to Section 1235.
The Legislature finds and declares all of the following:
(a)The epidemic of sexually transmitted infections in California has been growing since 2000.
(b)The most alarming increase has been in the number of all syphilis cases, rising 287 percent in the last 10 years of published data reported by the State Department of Public Health.
(c)The impact of syphilis among females has been even greater, increasing 1,113 percent over the same period.
(d)Particularly tragic is that the persistence of syphilis infections among women in their reproductive years has led to a meteoric rise in congenital syphilis, when the infection is transmitted from the mother to the child during pregnancy. Cases of congenital syphilis increased by 1,500 percent during the last 10 years, leading to hundreds of stillbirths, neonatal deaths, and other symptoms and complications.
(e)According to the United States Centers for Disease Control and Prevention (CDC), California has the 11th highest rate of congenital syphilis in the nation.
(f)Under existing law, health care providers are required to test a pregnant woman for syphilis at least twice: early in the pregnancy and during the third trimester.
(g)The State Department of Public Health states that a priority target for syphilis testing and treatment are people who can become pregnant and who face obstacles in obtaining healthcare.
(h)The CDC recommends screening asymptomatic women who are at increased risk for syphilis infection.
(i)The United States Preventive Services Task Force found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides a substantial benefit.
(j)The Los Angeles County Department of Public Health states, Since more than half of all pregnancies in [Los Angeles County] are unplanned, prevention, detection, and treatment of syphilis in women of reproductive age is important to eliminate congenital syphilis. All women of child-bearing age (15-44 years) should be tested for syphilis at least once.
(k)Routine syphilis testing provides an opportunity to educate people about syphilis, expand awareness among the general public about the adverse impacts of syphilis infection, and identify and treat any existing infections before a person becomes pregnant.
(l)Requiring providers on the front lines of health care services to offer a syphilis test is one known productive route to curb the persistent infection rates.
SEC. 2.Section 1216.5 is added to the Health and Safety Code, to read:1216.5.(a)A primary care clinic licensed under Section 1204 shall offer a syphilis test to all female patients between 15 and 44 years of age at least once per year.
(b)A violation of this section shall not constitute a crime pursuant to Section 1235.
|
Date
|
Status
|
|---|---|
| May 16, 2024 | In committee: Held under submission. |
| May 8, 2024 | In committee: Set, first hearing. Referred to APPR. suspense file. |
| Apr 30, 2024 | Re-referred to Com. on APPR. |
| Apr 29, 2024 | Read second time and amended. |
| Apr 25, 2024 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 2.) (April 23). |
| Apr 16, 2024 | In committee: Set, first hearing. Failed passage. Reconsideration granted. |
| Apr 3, 2024 | Re-referred to Com. on HEALTH. |
| Apr 2, 2024 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Mar 11, 2024 | Referred to Com. on HEALTH. |
| Feb 17, 2024 | From printer. May be heard in committee March 18. |
| Feb 16, 2024 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Apr 23, 2024 | Do pass as amended and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Health |
Passed |
|
| Apr 16, 2024 | Reconsideration. | Assembly Standing Committee on Health |
Passed |
|
| Apr 16, 2024 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Health |
Failed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| Aids Healthcare Foundation | ** Support | |
| American College Of Obstetricians And Gynecologists District Ix | ** Against | |
| AmericaS Physician Groups | ** Against | |
| California Medical Association | ** Against |
Date of Hearing: May 8, 2024
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
ABPCA Bill Id:AB 2960
Author:(Lee) – As Amended Ver:April 29, 2024
Policy Committee: | Health | Vote: | 5 - 4 |
Health | 16 - 0 | ||
Health | 9 - 2 |
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill requires a licensed primary care clinic (PCC) or hospital emergency department (ED) to annually offer a syphilis test to every patient who is sexually active and at least 15 years old. This bill exempts a PCC if it has tested the patient for syphilis, or the patient has declined an offered test, in the past 12 months. This bill sunsets on January 1, 2030.
FISCAL EFFECT:
The California Department of Public Health (CDPH) estimates costs of approximately $1.1 million over five years beginning in fiscal year (FY) 2024-25 to assess facilities’ compliance with the syphilis testing requirement during periodic relicensure surveys and complaint investigations (Licensing & Certification Fund). Specifically, CDPH’s Center for Health Care Quality (CHCQ) anticipates the need for a limited-term, full-time staff at a cost of $220,000 annually, to review facilities’ compliance with the bill during periodic relicensure surveys and investigations of complaints alleging noncompliance. In addition, CDPH’s Center for Infectious Diseases will answer technical assistance questions about this bill.
Unknown, but potentially significant, Medi-Cal cost pressure to test and treat patients for syphilis, potentially offset by an unknown amount for reduced treatment costs for infections and congenital syphilis (General Fund, federal funds).
According to the Legislative Analyst’s Office, the General Fund faces a structural deficit in the tens of billions of dollars over the next several fiscal years.
COMMENTS:
- Purpose. This bill is sponsored by the AIDS Healthcare Foundation. According to the author:
Cases of syphilis have been rising significantly in California, including cases of congenital syphilis that caused nearly 200 stillbirths or neonatal deaths between 2012 and 2021. This bill seeks to increase testing among women who may be pregnant so that proper treatment can be provided.
- Background. Syphilis is a bacterial sexually transmitted infection (STI) that typically spreads through sexual contact. The disease starts as a sore that is often painless and typically appears on the genitals, rectum, or mouth. Syphilis spreads from person to person through direct contact with these sores. It also can be passed to a baby during pregnancy and childbirth (congenital syphilis) and sometimes through breastfeeding. Syphilis bacteria can stay in the body for many years without causing symptoms; however, the infection can become active again. Without treatment, syphilis can damage the heart, brain or other organs. Syphilis can be cured, sometimes with a single shot of penicillin, when caught early.
Congenital syphilis (CS). CS can cause severe illness in infants, including premature birth, low birth weight, birth defects, blindness, hearing loss, stillbirth, and infant death. Tests and treatment for pregnant people are readily available. Over the last several years, California has experienced a steep increase in syphilis among females and in CS. From 2012 to 2021, female early syphilis cases increased over 1,113% and CS cases increased 1,500%, from 33 cases in 2012 to 528 cases in 2021.
CDPH Guidelines. In response to the alarming rise in CS, CDPH recognized an urgent need to expand syphilis detection among people who are or could become pregnant in order to ensure detection, timely treatment, and subsequent CS prevention. California STI screening recommendations to date have aligned with national guidelines, which recommend all pregnant patients receive syphilis screening at the first prenatal visit, with additional screening in the third trimester and at delivery for those with identified risk, including in communities and populations with high syphilis prevalence. Because the majority of California CS cases in 2017 and 2018 were born to patients with delayed or no prenatal care, CDPH additionally supports a more thorough, multipronged approach to case detection and CS prevention, including expanded syphilis screening for people who could become pregnant. This is especially important for people identified in settings such as the ED that serve populations at increased risk for syphilis and patients who might have disruptions in prenatal care and communicable disease treatment due to social factors. CDPH recommends, in addition to the guidelines stated above:
- ED providers in health jurisdictions with high-CS morbidity should consider confirming the syphilis status of all pregnant patients prior to discharge, either via documented test results in pregnancy, or a syphilis test in the ED if documentation is unavailable.
- All people who are or could become pregnant entering an adult correctional facility in a local health jurisdiction with high CS prevalence should be screened for syphilis at intake, or as close to intake as feasible.
- All sexually active people who could become pregnant should receive at least one lifetime screen for syphilis, with additional screening for those at increased risk.
- All sexually active people who could become pregnant should be screened for syphilis at the time of each HIV test.
- ED providers in health jurisdictions with high-CS morbidity should consider confirming the syphilis status of all pregnant patients prior to discharge, either via documented test results in pregnancy, or a syphilis test in the ED if documentation is unavailable.
- Prior Legislation. SB 306 (Pan), Chapter 486, Statutes of 2021, requires every licensed health care professional providing prenatal care or attending a birthing patient at the time of delivery to provide syphilis screening and testing as outlined in the most recent published CDPH guidelines.
Analysis Prepared by: Allegra Kim / APPR. / (916) 319-2081
Date of Hearing: April 23, 2024
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
ABPCA Bill Id:AB 2960
Author:((Lee) – As Amended Ver:April 2, 2024
SUBJECT: Sexually transmitted diseases: testing.
SUMMARY: Requires a licensed primary care clinic or hospital emergency department (ED) to offer a syphilis test at least once per year to all patients who can become pregnant. Prohibits a violation of these provisions from being a crime. Makes findings and declarations regarding the alarming increase of syphilis cases, rising 287% in the last 10 years of Department of Public Health (DPH) data. Specifically, this bill:
- Requires, at least once per year, a primary care clinic or a hospital ED to offer a syphilis test to patients who can become pregnant. Exempts a primary care clinic if the patient’s primary care clinic has tested the patient for syphilis or if the patient has been offered a syphilis test and declined the test within the previous 12 months.
- Authorizes a primary care clinic or ED to charge a patient to cover the cost of syphilis testing. Deems the primary care clinic or ED to have complied with this bill if a syphilis test is offered.
- States that it is the intent of the Legislature that if there is a shortage of bicillin, the preferred treatment for pregnant persons with syphilis, bicillin should be provided first to persons who are pregnant.
- Makes findings and declarations regarding the alarming increase of syphilis cases, rising 287% in the last 10 years of DPH data
EXISTING LAW:
- Establishes DPH, directed by a state Public Health Officer (PHO), to be vested with all the duties, powers, purposes, functions, responsibilities, and jurisdiction as they relate to public health and licensing of health facilities, as specified. Gives the PHO broad authority to detect, monitor, and prevent the spread of communicable disease in the state. [Health and Safety Code (HSC) §131050 and §120130, et seq.]
- Exempts various types of clinics from licensure and regulation by DPH, including any place or establishment owned or operated as a clinic or office by one or more licensed health care practitioners and used as an office for the practice of their profession, and any clinic operated as an outpatient department of a hospital. [HSC §1206]
- Defines “outpatient setting,” for purposes of establishing standards for accreditation of surgical settings that are not otherwise licensed, as any facility, clinic, unlicensed clinic, center, office, or other setting that is not part of a general acute care hospital (GACH), and where anesthesia, except local anesthesia or peripheral nerve blocks, is used in compliance with the community standard of practice in doses that have the probability of placing a patient at risk for loss of the patient’s life-preserving protective reflexes. [HSC §1248]
- Requires every health care provider, knowing of or in attendance on a case or suspected case of a disease on the list of reportable diseases and conditions, to be reported as required to DPH, including syphilis. [Title 17, California Code of Regulations (CCR) §2500, §2593, §2641.5- 2643.20, and §2800-2812]
- Requires a person who works in a health facility, service or operation, or who has occupational tuberculosis (TB) exposure in public health services in connection with health care to be periodically screened for TB. [Title 22, CCR Div. 5, Chapters 1-12]
- Requires an adult patient who receives primary care services to be offered a hepatitis B and C screening test according to the latest recommendations from the U.S. Preventive Services Task Force (USPSTF), and to the extent these services are covered under the patient's health insurance, unless the patient lacks capacity to consent to the test, or is being treated in the ED of a GACH. [HSC §1316.7]
FISCAL EFFECT: Unknown. This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, cases of syphilis have been rising significantly in California, including cases of congenital syphilis (CS) that caused nearly 200 stillbirths or neonatal deaths between 2012 and 2021. This bill seeks to increase testing among people who may be pregnant so that proper treatment can be provided.
- BACKGROUND. Syphilis is an infection caused by bacteria. Most often, it spreads through sexual contact. The disease starts as a sore that's often painless and typically appears on the genitals, rectum, or mouth. Syphilis spreads from person to person through direct contact with these sores. It also can be passed to a baby during pregnancy and childbirth and sometimes through breastfeeding. After the infection happens, syphilis bacteria can stay in the body for many years without causing symptoms, however the infection can become active again. Without treatment, syphilis can damage the heart, brain or other organs. Early syphilis can be cured, sometimes with a single shot of penicillin.
- Centers for Disease Control and Prevention (CDC) guidelines. According to the CDC, syphilis case reports continue to increase since reaching a historic low in 2000 and 2001. During 2021, there were 176,713 new cases of syphilis (all stages). Gay, bisexual, and other men who have sex with men (MSM) are experiencing extreme effects of syphilis. They account for 36% of all primary and secondary (P&S) syphilis cases in the 2021 sexually transmitted disease (STD) Surveillance Report. They also account for 47% of all male P&S cases. However, case rates are increasing among heterosexual men and women in recent years. CS continues to be a concern in the United States. CS occurs when a pregnant person passes syphilis to their baby. Final 2021 data show more than 2,800 cases of CS. The CDC screening recommendations are as follows:
- Screen asymptomatic women at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity) for syphilis infection;
- Pregnant Women:
- All pregnant women at the first prenatal visit; and,
- Retest at 28 weeks gestation and at delivery if at increased risk due to geography or personal risk (substance use, sexually transmitted infections (STIs) during pregnancy, multiple partners, a new partner, partner with STIs).
- Men Who Have Sex With Women: Screen asymptomatic adults at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity, and being a male younger than 29 years) for syphilis infection;
- MSM:
- At least annually for sexually active MSM; and,
- Every three to six months if at increased risk.
- Screen asymptomatic adults at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity, and being a male younger than 29 years) for syphilis infection;
- Transgender and Gender Diverse People: Consider screening at least annually based on reported sexual behaviors and exposure;
- Persons with HIV:
- For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter; and,
- More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology.
- CS. CS is an infection transmitted from pregnant person to child during pregnancy and/or delivery caused by the bacterium Treponema pallidum. CS can cause severe illness in infants including premature birth, low birth weight, birth defects, blindness, and hearing loss. It can also lead to stillbirth and infant death. Tests and treatment for pregnant people are readily available.
- Centers for Disease Control and Prevention (CDC) guidelines. According to the CDC, syphilis case reports continue to increase since reaching a historic low in 2000 and 2001. During 2021, there were 176,713 new cases of syphilis (all stages). Gay, bisexual, and other men who have sex with men (MSM) are experiencing extreme effects of syphilis. They account for 36% of all primary and secondary (P&S) syphilis cases in the 2021 sexually transmitted disease (STD) Surveillance Report. They also account for 47% of all male P&S cases. However, case rates are increasing among heterosexual men and women in recent years. CS continues to be a concern in the United States. CS occurs when a pregnant person passes syphilis to their baby. Final 2021 data show more than 2,800 cases of CS. The CDC screening recommendations are as follows:
Over the last several years, California has experienced a steep increase in syphilis among females and in CS. From 2012 to 2021, female early syphilis cases increased over 1,113% and CS cases increased 1,500%, from 33 cases in 2012 to 528 cases in 2021. This is the highest number of reported CS cases since 1992 when 522 cases were reported. According to the CDC, California had the 11th highest CS rate of all states in 2021. Thirty-seven (60.7%) of California’s 61 local health jurisdictions reported at least one case of CS in 2021. Most pregnant females who gave birth to infants with CS received prenatal care late in pregnancy or not at all.
- DPH guidelines. In response to the alarming rise in CS, DPH recognized an urgent need to expand syphilis detection among people who are or could become pregnant in order to ensure detection, timely treatment, and subsequent CS prevention. California STD screening recommendations to date have aligned with national guidelines, which recommend all pregnant patients receive syphilis screening at the first prenatal visit, with additional screening in the third trimester and at delivery for those with identified risk, including in communities and populations with high syphilis prevalence. Because the majority of California CS cases in 2017 and 2018 were born to pregnant patients with delayed or no prenatal care, DPH supports a more thorough, multipronged approach to case detection and CS prevention, which includes expanded syphilis screening for people who could become pregnant. This is especially important for people identified in settings that serve populations at increased risk for syphilis, as well as patients who might have disruptions in prenatal care and communicable disease treatment due to contributing social factors (e.g., substance use, incarceration, poverty, homelessness, etc.), such as the ED. DPH recommends:
- All pregnant patients should be screened for syphilis at least twice during pregnancy: once at either confirmation of pregnancy or at the first prenatal encounter (ideally during the first trimester) – and again during the third trimester (ideally between 28–32 weeks’ gestation), regardless of whether such testing was performed or offered during the first two trimesters;
- Patients should be screened for syphilis at delivery, except those at low risk who have a documented negative screen in the third trimester;
- ED providers in local health jurisdictions with high-CS morbidity should consider confirming the syphilis status of all pregnant patients prior to discharge, either via documented test results in pregnancy, or a syphilis test in the ED if documentation is unavailable;
- All people who are or could become pregnant entering an adult correctional facility health jurisdiction with high-CS morbidity should be screened for syphilis at intake, or as close to intake as feasible;
- All sexually active people who could become pregnant should receive at least one lifetime screen for syphilis, with additional screening for those at increased risk; and,
- All sexually active people who could become pregnant should be screened for syphilis at the time of each HIV test.
- DPH guidelines. In response to the alarming rise in CS, DPH recognized an urgent need to expand syphilis detection among people who are or could become pregnant in order to ensure detection, timely treatment, and subsequent CS prevention. California STD screening recommendations to date have aligned with national guidelines, which recommend all pregnant patients receive syphilis screening at the first prenatal visit, with additional screening in the third trimester and at delivery for those with identified risk, including in communities and populations with high syphilis prevalence. Because the majority of California CS cases in 2017 and 2018 were born to pregnant patients with delayed or no prenatal care, DPH supports a more thorough, multipronged approach to case detection and CS prevention, which includes expanded syphilis screening for people who could become pregnant. This is especially important for people identified in settings that serve populations at increased risk for syphilis, as well as patients who might have disruptions in prenatal care and communicable disease treatment due to contributing social factors (e.g., substance use, incarceration, poverty, homelessness, etc.), such as the ED. DPH recommends:
- SUPPORT. AIDS Healthcare Foundation (AHF) is the sponsor of this bill and states that the epidemic of STIs in California has been growing since 2000. The most alarming increase has been in the number of all syphilis cases, rising 287% in the last 10 years as reported by DPH. The impact of syphilis among females has been even greater, increasing 1,113% over the same period. California is outpacing the rest of the country, with a rate that is 41% higher than the national rate. Particularly tragic is that the persistence of syphilis infections among women in their reproductive years has led to a meteoric rise in CS, when the infection is transmitted from the mother to the child during pregnancy. Cases of CS increased by 1500% during the last 10 years, leading to hundreds of stillbirths, neonatal deaths and other symptoms and complications. According to the CDC, California has the 11th highest rate of CS in the nation, which is 63% higher than the national rate. AHF notes that both DPH and the CDC agree that a priority target for syphilis testing and treatment are people who can become pregnant and who face obstacles in obtaining healthcare. Moreover, the USPSTF found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. AHF concludes that a mandate to offer syphilis testing screen persons who are infected and allow medical professionals to treat them before the patient becomes pregnant, will provide an opportunity to educate people about syphilis and expand awareness among the public about the adverse impacts of syphilis infection and how to protect themselves.
- OPPOSE UNLESS AMENDED. The California Emergency Nurses Association (CA ENA) is opposed to this bill unless it is amended. CA ENA states that they believe mandating syphilis screening in EDs, even for a small portion of the qualifying patients cared for in EDs, would add to the burden of emergency providers in caring for very sick or injured patients, with an unintended consequence of increased ED crowding. Crowding occurs when the identified need for emergency services exceeds available resources for patient care in the ED, hospital, or both. Crowding is also related to decreased access/availability of services over the entire health care delivery system (e.g. skilled nursing facility beds, behavioral health services, hospital inpatient beds, home health care services, wound care services and any other service not available). When routine patient care, testing, and evaluation is required in an emergent environment, ED length of stay is often negatively impacted with prolonged results, and in effect, creates a higher patient volume waiting for those results. As the ED becomes increasingly crowded and patients must wait longer for care, frustration intensifies in patients/families and can lead to violence against healthcare providers.
CA ENA states that multiple studies have reported that the quality of care decreases as EDs become more crowded, and this bill will increase ED length of stay. CA ENA points to a DPH report published in 2019 found that, on average, EDs spend 28 minutes per patient offering the HIV test, securing consent, and providing information and counseling. CA ENA contends that one can presume it would take approximately 28 minutes to meet this mandate for syphilis screening – 28 minutes that could be dedicated to life-threatening or life-changing care for ED patients and their families.
- OPPOSITION. The American College of OB/GYN’s District IX (ACOG) writes in opposition that this bill requires syphilis testing to be offered to all women of reproductive age at least once per year regardless of clinical guidelines or recommendations. ACOG recommends all pregnant people are screened for syphilis at their first prenatal visit and potentially retested at delivery if at high risk; however, it does not recommend routine screening for all people who are not pregnant. A broad mandate that requires tests to be offered to all reproductive aged women regardless of risk, even when not needed or recommended through clinical guidance, could strain public health resources, diverting them from other critical areas or from higher risk populations, and take time away from why the women sought healthcare to begin with. Efficient and more cost-effective use of limited public health resources often requires prioritizing interventions based on risk assessments and epidemiological data. Rather than a blanket mandate, we should focus on high-risk groups, improve access to voluntary testing, and invest in education and prevention might yield better outcomes in terms of both health and economics.
The California Medical Association is opposed to this bill and states that like many other bills legislating medicine, this bill offers a “one-size-fits-all approach” that does not take into consideration the many other clinical factors. Efficient and more cost-effective use of limited public health resources often requires prioritizing interventions based on risk assessments and epidemiological data. Rather than a blanket mandate, public health strategies benefit more from being targeted and nuanced, focusing on higher-risk populations and tailored interventions based on clinical guidance. - RELATED LEGISLATION. AB 2132 (Low) requires an adult patient receiving primary care services in specified health care settings, to be offered a TB risk assessment and TB screening test, if certain conditions apply. AB 2132 is pending in the Assembly Appropriations Committee.
- PREVIOUS LEGISLATION.
- AB 789 (Low), Chapter 470, Statutes of 2021, requires an adult patient who receives primary care services to be offered a hepatitis B and C screening test according to the latest recommendations from the USPSTF, and to the extent these services are covered under the patient's health insurance, unless the patient lacks capacity to consent to the test, or is being treated in the ED of a GACH.
- SB 306 (Pan), Chapter 486, Statutes of 2021, permits pharmacists to dispense a drug, without the name of an individual for whom the drug is intended, when prescribed for the sexual partner of someone who has been diagnosed with a STD; prohibits health care providers who prescribe, dispense, or furnish such a drug from being subject to, civil, criminal, or administrative penalties, as specified; requires a syphilis blood test, during the third trimester of pregnancy and at delivery, as specified; requires public and commercial health coverage of home STD test kits; and, adds rapid STD tests to existing law which permits HIV counselors to perform rapid HIV and hepatitis C tests.
- AMENDMENTS. The author is proposing amendments to require syphilis testing in clinics and EDs as follows:
- As outlined in the most recent guidelines published by the CDC;
- To apply to a person who is sexually active and at least 15 years of age;
- To clarify that a clinic or ED may offer a syphilis test to a patient under the age of 15 as permitted under current law;
- To strike intent language regarding the preferred treatment for a pregnant person with syphilis; and,
- To add a five year sunset.
REGISTERED SUPPORT / OPPOSITION:
Support
AIDS Healthcare Foundation
Opposition
American College of Obstetricians and Gynecologists District IX
America’s Physician Groups
California Medical Association
Analysis Prepared by: Lara Flynn / HEALTH / (916) 319-2097
Date of Hearing: April 23, 2024
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
ABPCA Bill Id:AB 2960
Author:((Lee) – As Amended Ver:April 2, 2024
SUBJECT: Sexually transmitted diseases: testing.
SUMMARY: Requires a licensed primary care clinic or hospital emergency department (ED) to offer a syphilis test at least once per year to all patients who can become pregnant. Prohibits a violation of these provisions from being a crime. Makes findings and declarations regarding the alarming increase of syphilis cases, rising 287% in the last 10 years of Department of Public Health (DPH) data. Specifically, this bill:
- Requires, at least once per year, a primary care clinic or a hospital ED to offer a syphilis test to patients who can become pregnant. Exempts a primary care clinic if the patient’s primary care clinic has tested the patient for syphilis or if the patient has been offered a syphilis test and declined the test within the previous 12 months.
- Authorizes a primary care clinic or ED to charge a patient to cover the cost of syphilis testing. Deems the primary care clinic or ED to have complied with this bill if a syphilis test is offered.
- States that it is the intent of the Legislature that if there is a shortage of bicillin, the preferred treatment for pregnant persons with syphilis, bicillin should be provided first to persons who are pregnant.
- Makes findings and declarations regarding the alarming increase of syphilis cases, rising 287% in the last 10 years of DPH data
EXISTING LAW:
- Establishes DPH, directed by a state Public Health Officer (PHO), to be vested with all the duties, powers, purposes, functions, responsibilities, and jurisdiction as they relate to public health and licensing of health facilities, as specified. Gives the PHO broad authority to detect, monitor, and prevent the spread of communicable disease in the state. [Health and Safety Code (HSC) §131050 and §120130, et seq.]
- Exempts various types of clinics from licensure and regulation by DPH, including any place or establishment owned or operated as a clinic or office by one or more licensed health care practitioners and used as an office for the practice of their profession, and any clinic operated as an outpatient department of a hospital. [HSC §1206]
- Defines “outpatient setting,” for purposes of establishing standards for accreditation of surgical settings that are not otherwise licensed, as any facility, clinic, unlicensed clinic, center, office, or other setting that is not part of a general acute care hospital (GACH), and where anesthesia, except local anesthesia or peripheral nerve blocks, is used in compliance with the community standard of practice in doses that have the probability of placing a patient at risk for loss of the patient’s life-preserving protective reflexes. [HSC §1248]
- Requires every health care provider, knowing of or in attendance on a case or suspected case of a disease on the list of reportable diseases and conditions, to be reported as required to DPH, including syphilis. [Title 17, California Code of Regulations (CCR) §2500, §2593, §2641.5- 2643.20, and §2800-2812]
- Requires a person who works in a health facility, service or operation, or who has occupational tuberculosis (TB) exposure in public health services in connection with health care to be periodically screened for TB. [Title 22, CCR Div. 5, Chapters 1-12]
- Requires an adult patient who receives primary care services to be offered a hepatitis B and C screening test according to the latest recommendations from the U.S. Preventive Services Task Force (USPSTF), and to the extent these services are covered under the patient's health insurance, unless the patient lacks capacity to consent to the test, or is being treated in the ED of a GACH. [HSC §1316.7]
FISCAL EFFECT: Unknown. This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, cases of syphilis have been rising significantly in California, including cases of congenital syphilis (CS) that caused nearly 200 stillbirths or neonatal deaths between 2012 and 2021. This bill seeks to increase testing among people who may be pregnant so that proper treatment can be provided.
- BACKGROUND. Syphilis is an infection caused by bacteria. Most often, it spreads through sexual contact. The disease starts as a sore that's often painless and typically appears on the genitals, rectum, or mouth. Syphilis spreads from person to person through direct contact with these sores. It also can be passed to a baby during pregnancy and childbirth and sometimes through breastfeeding. After the infection happens, syphilis bacteria can stay in the body for many years without causing symptoms, however the infection can become active again. Without treatment, syphilis can damage the heart, brain or other organs. Early syphilis can be cured, sometimes with a single shot of penicillin.
- Centers for Disease Control and Prevention (CDC) guidelines. According to the CDC, syphilis case reports continue to increase since reaching a historic low in 2000 and 2001. During 2021, there were 176,713 new cases of syphilis (all stages). Gay, bisexual, and other men who have sex with men (MSM) are experiencing extreme effects of syphilis. They account for 36% of all primary and secondary (P&S) syphilis cases in the 2021 sexually transmitted disease (STD) Surveillance Report. They also account for 47% of all male P&S cases. However, case rates are increasing among heterosexual men and women in recent years. CS continues to be a concern in the United States. CS occurs when a pregnant person passes syphilis to their baby. Final 2021 data show more than 2,800 cases of CS. The CDC screening recommendations are as follows:
- Screen asymptomatic women at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity) for syphilis infection;
- Pregnant Women:
- All pregnant women at the first prenatal visit; and,
- Retest at 28 weeks gestation and at delivery if at increased risk due to geography or personal risk (substance use, sexually transmitted infections (STIs) during pregnancy, multiple partners, a new partner, partner with STIs).
- Men Who Have Sex With Women: Screen asymptomatic adults at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity, and being a male younger than 29 years) for syphilis infection;
- MSM:
- At least annually for sexually active MSM; and,
- Every three to six months if at increased risk.
- Screen asymptomatic adults at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity, and being a male younger than 29 years) for syphilis infection;
- Transgender and Gender Diverse People: Consider screening at least annually based on reported sexual behaviors and exposure;
- Persons with HIV:
- For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter; and,
- More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology.
- CS. CS is an infection transmitted from pregnant person to child during pregnancy and/or delivery caused by the bacterium Treponema pallidum. CS can cause severe illness in infants including premature birth, low birth weight, birth defects, blindness, and hearing loss. It can also lead to stillbirth and infant death. Tests and treatment for pregnant people are readily available.
- Centers for Disease Control and Prevention (CDC) guidelines. According to the CDC, syphilis case reports continue to increase since reaching a historic low in 2000 and 2001. During 2021, there were 176,713 new cases of syphilis (all stages). Gay, bisexual, and other men who have sex with men (MSM) are experiencing extreme effects of syphilis. They account for 36% of all primary and secondary (P&S) syphilis cases in the 2021 sexually transmitted disease (STD) Surveillance Report. They also account for 47% of all male P&S cases. However, case rates are increasing among heterosexual men and women in recent years. CS continues to be a concern in the United States. CS occurs when a pregnant person passes syphilis to their baby. Final 2021 data show more than 2,800 cases of CS. The CDC screening recommendations are as follows:
Over the last several years, California has experienced a steep increase in syphilis among females and in CS. From 2012 to 2021, female early syphilis cases increased over 1,113% and CS cases increased 1,500%, from 33 cases in 2012 to 528 cases in 2021. This is the highest number of reported CS cases since 1992 when 522 cases were reported. According to the CDC, California had the 11th highest CS rate of all states in 2021. Thirty-seven (60.7%) of California’s 61 local health jurisdictions reported at least one case of CS in 2021. Most pregnant females who gave birth to infants with CS received prenatal care late in pregnancy or not at all.
- DPH guidelines. In response to the alarming rise in CS, DPH recognized an urgent need to expand syphilis detection among people who are or could become pregnant in order to ensure detection, timely treatment, and subsequent CS prevention. California STD screening recommendations to date have aligned with national guidelines, which recommend all pregnant patients receive syphilis screening at the first prenatal visit, with additional screening in the third trimester and at delivery for those with identified risk, including in communities and populations with high syphilis prevalence. Because the majority of California CS cases in 2017 and 2018 were born to pregnant patients with delayed or no prenatal care, DPH supports a more thorough, multipronged approach to case detection and CS prevention, which includes expanded syphilis screening for people who could become pregnant. This is especially important for people identified in settings that serve populations at increased risk for syphilis, as well as patients who might have disruptions in prenatal care and communicable disease treatment due to contributing social factors (e.g., substance use, incarceration, poverty, homelessness, etc.), such as the ED. DPH recommends:
- All pregnant patients should be screened for syphilis at least twice during pregnancy: once at either confirmation of pregnancy or at the first prenatal encounter (ideally during the first trimester) – and again during the third trimester (ideally between 28–32 weeks’ gestation), regardless of whether such testing was performed or offered during the first two trimesters;
- Patients should be screened for syphilis at delivery, except those at low risk who have a documented negative screen in the third trimester;
- ED providers in local health jurisdictions with high-CS morbidity should consider confirming the syphilis status of all pregnant patients prior to discharge, either via documented test results in pregnancy, or a syphilis test in the ED if documentation is unavailable;
- All people who are or could become pregnant entering an adult correctional facility health jurisdiction with high-CS morbidity should be screened for syphilis at intake, or as close to intake as feasible;
- All sexually active people who could become pregnant should receive at least one lifetime screen for syphilis, with additional screening for those at increased risk; and,
- All sexually active people who could become pregnant should be screened for syphilis at the time of each HIV test.
- DPH guidelines. In response to the alarming rise in CS, DPH recognized an urgent need to expand syphilis detection among people who are or could become pregnant in order to ensure detection, timely treatment, and subsequent CS prevention. California STD screening recommendations to date have aligned with national guidelines, which recommend all pregnant patients receive syphilis screening at the first prenatal visit, with additional screening in the third trimester and at delivery for those with identified risk, including in communities and populations with high syphilis prevalence. Because the majority of California CS cases in 2017 and 2018 were born to pregnant patients with delayed or no prenatal care, DPH supports a more thorough, multipronged approach to case detection and CS prevention, which includes expanded syphilis screening for people who could become pregnant. This is especially important for people identified in settings that serve populations at increased risk for syphilis, as well as patients who might have disruptions in prenatal care and communicable disease treatment due to contributing social factors (e.g., substance use, incarceration, poverty, homelessness, etc.), such as the ED. DPH recommends:
- SUPPORT. AIDS Healthcare Foundation (AHF) is the sponsor of this bill and states that the epidemic of STIs in California has been growing since 2000. The most alarming increase has been in the number of all syphilis cases, rising 287% in the last 10 years as reported by DPH. The impact of syphilis among females has been even greater, increasing 1,113% over the same period. California is outpacing the rest of the country, with a rate that is 41% higher than the national rate. Particularly tragic is that the persistence of syphilis infections among women in their reproductive years has led to a meteoric rise in CS, when the infection is transmitted from the mother to the child during pregnancy. Cases of CS increased by 1500% during the last 10 years, leading to hundreds of stillbirths, neonatal deaths and other symptoms and complications. According to the CDC, California has the 11th highest rate of CS in the nation, which is 63% higher than the national rate. AHF notes that both DPH and the CDC agree that a priority target for syphilis testing and treatment are people who can become pregnant and who face obstacles in obtaining healthcare. Moreover, the USPSTF found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. AHF concludes that a mandate to offer syphilis testing screen persons who are infected and allow medical professionals to treat them before the patient becomes pregnant, will provide an opportunity to educate people about syphilis and expand awareness among the public about the adverse impacts of syphilis infection and how to protect themselves.
- OPPOSE UNLESS AMENDED. The California Emergency Nurses Association (CA ENA) is opposed to this bill unless it is amended. CA ENA states that they believe mandating syphilis screening in EDs, even for a small portion of the qualifying patients cared for in EDs, would add to the burden of emergency providers in caring for very sick or injured patients, with an unintended consequence of increased ED crowding. Crowding occurs when the identified need for emergency services exceeds available resources for patient care in the ED, hospital, or both. Crowding is also related to decreased access/availability of services over the entire health care delivery system (e.g. skilled nursing facility beds, behavioral health services, hospital inpatient beds, home health care services, wound care services and any other service not available). When routine patient care, testing, and evaluation is required in an emergent environment, ED length of stay is often negatively impacted with prolonged results, and in effect, creates a higher patient volume waiting for those results. As the ED becomes increasingly crowded and patients must wait longer for care, frustration intensifies in patients/families and can lead to violence against healthcare providers.
CA ENA states that multiple studies have reported that the quality of care decreases as EDs become more crowded, and this bill will increase ED length of stay. CA ENA points to a DPH report published in 2019 found that, on average, EDs spend 28 minutes per patient offering the HIV test, securing consent, and providing information and counseling. CA ENA contends that one can presume it would take approximately 28 minutes to meet this mandate for syphilis screening – 28 minutes that could be dedicated to life-threatening or life-changing care for ED patients and their families.
- OPPOSITION. The American College of OB/GYN’s District IX (ACOG) writes in opposition that this bill requires syphilis testing to be offered to all women of reproductive age at least once per year regardless of clinical guidelines or recommendations. ACOG recommends all pregnant people are screened for syphilis at their first prenatal visit and potentially retested at delivery if at high risk; however, it does not recommend routine screening for all people who are not pregnant. A broad mandate that requires tests to be offered to all reproductive aged women regardless of risk, even when not needed or recommended through clinical guidance, could strain public health resources, diverting them from other critical areas or from higher risk populations, and take time away from why the women sought healthcare to begin with. Efficient and more cost-effective use of limited public health resources often requires prioritizing interventions based on risk assessments and epidemiological data. Rather than a blanket mandate, we should focus on high-risk groups, improve access to voluntary testing, and invest in education and prevention might yield better outcomes in terms of both health and economics.
The California Medical Association is opposed to this bill and states that like many other bills legislating medicine, this bill offers a “one-size-fits-all approach” that does not take into consideration the many other clinical factors. Efficient and more cost-effective use of limited public health resources often requires prioritizing interventions based on risk assessments and epidemiological data. Rather than a blanket mandate, public health strategies benefit more from being targeted and nuanced, focusing on higher-risk populations and tailored interventions based on clinical guidance. - RELATED LEGISLATION. AB 2132 (Low) requires an adult patient receiving primary care services in specified health care settings, to be offered a TB risk assessment and TB screening test, if certain conditions apply. AB 2132 is pending in the Assembly Appropriations Committee.
- PREVIOUS LEGISLATION.
- AB 789 (Low), Chapter 470, Statutes of 2021, requires an adult patient who receives primary care services to be offered a hepatitis B and C screening test according to the latest recommendations from the USPSTF, and to the extent these services are covered under the patient's health insurance, unless the patient lacks capacity to consent to the test, or is being treated in the ED of a GACH.
- SB 306 (Pan), Chapter 486, Statutes of 2021, permits pharmacists to dispense a drug, without the name of an individual for whom the drug is intended, when prescribed for the sexual partner of someone who has been diagnosed with a STD; prohibits health care providers who prescribe, dispense, or furnish such a drug from being subject to, civil, criminal, or administrative penalties, as specified; requires a syphilis blood test, during the third trimester of pregnancy and at delivery, as specified; requires public and commercial health coverage of home STD test kits; and, adds rapid STD tests to existing law which permits HIV counselors to perform rapid HIV and hepatitis C tests.
- AMENDMENTS. The author is proposing amendments to require syphilis testing in clinics and EDs as follows:
- As outlined in the most recent guidelines published by the CDC;
- To apply to a person who is sexually active and at least 15 years of age;
- To clarify that a clinic or ED may offer a syphilis test to a patient under the age of 15 as permitted under current law; and,
- To strike intent language regarding the preferred treatment for a pregnant person with syphilis.
REGISTERED SUPPORT / OPPOSITION:
Support
AIDS Healthcare Foundation
Opposition
American College of Obstetricians and Gynecologists District IX
America’s Physician Groups
California Medical Association
Analysis Prepared by: Lara Flynn / HEALTH / (916) 319-2097
Date of Hearing: April 16, 2024
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
ABPCA Bill Id:AB 2960
Author:((Lee) – As Amended Ver:April 2, 2024
SUBJECT: Sexually transmitted diseases: testing.
SUMMARY: Requires a licensed primary care clinic or hospital emergency department (ED) to offer a syphilis test at least once per year to all patients who can become pregnant. Prohibits a violation of these provisions from being a crime. Makes findings and declarations regarding the alarming increase of syphilis cases, rising 287% in the last 10 years of Department of Public Health (DPH) data. Specifically, this bill:
- Requires, at least once per year, a primary care clinic or a hospital ED to offer a syphilis test to patients who can become pregnant. Exempts a primary care clinic if the patient’s primary care clinic has tested the patient for syphilis or if the patient has been offered a syphilis test and declined the test within the previous 12 months.
- Authorizes a primary care clinic or ED to charge a patient to cover the cost of syphilis testing. Deems the primary care clinic or ED to have complied with this bill if a syphilis test is offered.
- States that it is the intent of the Legislature that if there is a shortage of bicillin, the preferred treatment for pregnant persons with syphilis, bicillin should be provided first to persons who are pregnant.
- Makes findings and declarations regarding the alarming increase of syphilis cases, rising 287% in the last 10 years of DPH data
EXISTING LAW:
- Establishes DPH, directed by a state Public Health Officer (PHO), to be vested with all the duties, powers, purposes, functions, responsibilities, and jurisdiction as they relate to public health and licensing of health facilities, as specified. Gives the PHO broad authority to detect, monitor, and prevent the spread of communicable disease in the state. [Health and Safety Code (HSC) §131050 and §120130, et seq.]
- Exempts various types of clinics from licensure and regulation by DPH, including any place or establishment owned or operated as a clinic or office by one or more licensed health care practitioners and used as an office for the practice of their profession, and any clinic operated as an outpatient department of a hospital. [HSC §1206]
- Defines “outpatient setting,” for purposes of establishing standards for accreditation of surgical settings that are not otherwise licensed, as any facility, clinic, unlicensed clinic, center, office, or other setting that is not part of a general acute care hospital (GACH), and where anesthesia, except local anesthesia or peripheral nerve blocks, is used in compliance with the community standard of practice in doses that have the probability of placing a patient at risk for loss of the patient’s life-preserving protective reflexes. [HSC §1248]
- Requires every health care provider, knowing of or in attendance on a case or suspected case of a disease on the list of reportable diseases and conditions, to be reported as required to DPH, including syphilis. [Title 17, California Code of Regulations (CCR) §2500, §2593, §2641.5- 2643.20, and §2800-2812]
- Requires a person who works in a health facility, service or operation, or who has occupational tuberculosis (TB) exposure in public health services in connection with health care to be periodically screened for TB. [Title 22, CCR Div. 5, Chapters 1-12]
- Requires an adult patient who receives primary care services to be offered a hepatitis B and C screening test according to the latest recommendations from the U.S. Preventive Services Task Force (USPSTF), and to the extent these services are covered under the patient's health insurance, unless the patient lacks capacity to consent to the test, or is being treated in the ED of a GACH. [HSC §1316.7]
FISCAL EFFECT: Unknown. This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, cases of syphilis have been rising significantly in California, including cases of congenital syphilis (CS) that caused nearly 200 stillbirths or neonatal deaths between 2012 and 2021. This bill seeks to increase testing among people who may be pregnant so that proper treatment can be provided.
- BACKGROUND. Syphilis is an infection caused by bacteria. Most often, it spreads through sexual contact. The disease starts as a sore that's often painless and typically appears on the genitals, rectum, or mouth. Syphilis spreads from person to person through direct contact with these sores. It also can be passed to a baby during pregnancy and childbirth and sometimes through breastfeeding. After the infection happens, syphilis bacteria can stay in the body for many years without causing symptoms, however the infection can become active again. Without treatment, syphilis can damage the heart, brain or other organs. Early syphilis can be cured, sometimes with a single shot of penicillin.
- Centers for Disease Control and Prevention (CDC) guidelines. According to the CDC, syphilis case reports continue to increase since reaching a historic low in 2000 and 2001. During 2021, there were 176,713 new cases of syphilis (all stages). Gay, bisexual, and other men who have sex with men (MSM) are experiencing extreme effects of syphilis. They account for 36% of all primary and secondary (P&S) syphilis cases in the 2021 sexually transmitted disease (STD) Surveillance Report. They also account for 47% of all male P&S cases. However, case rates are increasing among heterosexual men and women in recent years. CS continues to be a concern in the United States. CS occurs when a pregnant person passes syphilis to their baby. Final 2021 data show more than 2,800 cases of CS. The CDC screening recommendations are as follows:
- Screen asymptomatic women at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity) for syphilis infection;
- Pregnant Women:
- All pregnant women at the first prenatal visit; and,
- Retest at 28 weeks gestation and at delivery if at increased risk due to geography or personal risk (substance use, sexually transmitted infections (STIs) during pregnancy, multiple partners, a new partner, partner with STIs).
- Men Who Have Sex With Women: Screen asymptomatic adults at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity, and being a male younger than 29 years) for syphilis infection;
- MSM:
- At least annually for sexually active MSM; and,
- Every three to six months if at increased risk.
- Screen asymptomatic adults at increased risk (history of incarceration or transactional sex work, geography, race/ethnicity, and being a male younger than 29 years) for syphilis infection;
- Transgender and Gender Diverse People: Consider screening at least annually based on reported sexual behaviors and exposure;
- Persons with HIV:
- For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter; and,
- More frequent screening might be appropriate depending on individual risk behaviors and the local epidemiology.
- CS. CS is an infection transmitted from pregnant person to child during pregnancy and/or delivery caused by the bacterium Treponema pallidum. CS can cause severe illness in infants including premature birth, low birth weight, birth defects, blindness, and hearing loss. It can also lead to stillbirth and infant death. Tests and treatment for pregnant people are readily available.
- Centers for Disease Control and Prevention (CDC) guidelines. According to the CDC, syphilis case reports continue to increase since reaching a historic low in 2000 and 2001. During 2021, there were 176,713 new cases of syphilis (all stages). Gay, bisexual, and other men who have sex with men (MSM) are experiencing extreme effects of syphilis. They account for 36% of all primary and secondary (P&S) syphilis cases in the 2021 sexually transmitted disease (STD) Surveillance Report. They also account for 47% of all male P&S cases. However, case rates are increasing among heterosexual men and women in recent years. CS continues to be a concern in the United States. CS occurs when a pregnant person passes syphilis to their baby. Final 2021 data show more than 2,800 cases of CS. The CDC screening recommendations are as follows:
Over the last several years, California has experienced a steep increase in syphilis among females and in CS. From 2012 to 2021, female early syphilis cases increased over 1,113% and CS cases increased 1,500%, from 33 cases in 2012 to 528 cases in 2021. This is the highest number of reported CS cases since 1992 when 522 cases were reported. According to the CDC, California had the 11th highest CS rate of all states in 2021. Thirty-seven (60.7%) of California’s 61 local health jurisdictions reported at least one case of CS in 2021. Most pregnant females who gave birth to infants with CS received prenatal care late in pregnancy or not at all.
- DPH guidelines. In response to the alarming rise in CS, DPH recognized an urgent need to expand syphilis detection among people who are or could become pregnant in order to ensure detection, timely treatment, and subsequent CS prevention. California STD screening recommendations to date have aligned with national guidelines, which recommend all pregnant patients receive syphilis screening at the first prenatal visit, with additional screening in the third trimester and at delivery for those with identified risk, including in communities and populations with high syphilis prevalence. Because the majority of California CS cases in 2017 and 2018 were born to pregnant patients with delayed or no prenatal care, DPH supports a more thorough, multipronged approach to case detection and CS prevention, which includes expanded syphilis screening for people who could become pregnant. This is especially important for people identified in settings that serve populations at increased risk for syphilis, as well as patients who might have disruptions in prenatal care and communicable disease treatment due to contributing social factors (e.g., substance use, incarceration, poverty, homelessness, etc.), such as the ED. DPH recommends:
- All pregnant patients should be screened for syphilis at least twice during pregnancy: once at either confirmation of pregnancy or at the first prenatal encounter (ideally during the first trimester) – and again during the third trimester (ideally between 28–32 weeks’ gestation), regardless of whether such testing was performed or offered during the first two trimesters;
- Patients should be screened for syphilis at delivery, except those at low risk who have a documented negative screen in the third trimester;
- ED providers in local health jurisdictions with high-CS morbidity should consider confirming the syphilis status of all pregnant patients prior to discharge, either via documented test results in pregnancy, or a syphilis test in the ED if documentation is unavailable;
- All people who are or could become pregnant entering an adult correctional facility health jurisdiction with high-CS morbidity should be screened for syphilis at intake, or as close to intake as feasible;
- All sexually active people who could become pregnant should receive at least one lifetime screen for syphilis, with additional screening for those at increased risk; and,
- All sexually active people who could become pregnant should be screened for syphilis at the time of each HIV test.
- DPH guidelines. In response to the alarming rise in CS, DPH recognized an urgent need to expand syphilis detection among people who are or could become pregnant in order to ensure detection, timely treatment, and subsequent CS prevention. California STD screening recommendations to date have aligned with national guidelines, which recommend all pregnant patients receive syphilis screening at the first prenatal visit, with additional screening in the third trimester and at delivery for those with identified risk, including in communities and populations with high syphilis prevalence. Because the majority of California CS cases in 2017 and 2018 were born to pregnant patients with delayed or no prenatal care, DPH supports a more thorough, multipronged approach to case detection and CS prevention, which includes expanded syphilis screening for people who could become pregnant. This is especially important for people identified in settings that serve populations at increased risk for syphilis, as well as patients who might have disruptions in prenatal care and communicable disease treatment due to contributing social factors (e.g., substance use, incarceration, poverty, homelessness, etc.), such as the ED. DPH recommends:
- SUPPORT. AIDS Healthcare Foundation (AHF) is the sponsor of this bill and states that the epidemic of STIs in California has been growing since 2000. The most alarming increase has been in the number of all syphilis cases, rising 287% in the last 10 years as reported by DPH. The impact of syphilis among females has been even greater, increasing 1,113% over the same period. California is outpacing the rest of the country, with a rate that is 41% higher than the national rate. Particularly tragic is that the persistence of syphilis infections among women in their reproductive years has led to a meteoric rise in CS, when the infection is transmitted from the mother to the child during pregnancy. Cases of CS increased by 1500% during the last 10 years, leading to hundreds of stillbirths, neonatal deaths and other symptoms and complications. According to the CDC, California has the 11th highest rate of CS in the nation, which is 63% higher than the national rate. AHF notes that both DPH and the CDC agree that a priority target for syphilis testing and treatment are people who can become pregnant and who face obstacles in obtaining healthcare. Moreover, the USPSTF found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. AHF concludes that a mandate to offer syphilis testing screen persons who are infected and allow medical professionals to treat them before the patient becomes pregnant, will provide an opportunity to educate people about syphilis and expand awareness among the public about the adverse impacts of syphilis infection and how to protect themselves.
- OPPOSE UNLESS AMENDED. The California Emergency Nurses Association (CA ENA) is opposed to this bill unless it is amended. CA ENA states that they believe mandating syphilis screening in EDs, even for a small portion of the qualifying patients cared for in EDs, would add to the burden of emergency providers in caring for very sick or injured patients, with an unintended consequence of increased ED crowding. Crowding occurs when the identified need for emergency services exceeds available resources for patient care in the ED, hospital, or both. Crowding is also related to decreased access/availability of services over the entire health care delivery system (e.g. skilled nursing facility beds, behavioral health services, hospital inpatient beds, home health care services, wound care services and any other service not available). When routine patient care, testing, and evaluation is required in an emergent environment, ED length of stay is often negatively impacted with prolonged results, and in effect, creates a higher patient volume waiting for those results. As the ED becomes increasingly crowded and patients must wait longer for care, frustration intensifies in patients/families and can lead to violence against healthcare providers.
CA ENA states that multiple studies have reported that the quality of care decreases as EDs become more crowded, and this bill will increase ED length of stay. CA ENA points to a DPH report published in 2019 found that, on average, EDs spend 28 minutes per patient offering the HIV test, securing consent, and providing information and counseling. CA ENA contends that one can presume it would take approximately 28 minutes to meet this mandate for syphilis screening – 28 minutes that could be dedicated to life-threatening or life-changing care for ED patients and their families.
- OPPOSITION. The American College of OB/GYN’s District IX (ACOG) writes in opposition that this bill requires syphilis testing to be offered to all women of reproductive age at least once per year regardless of clinical guidelines or recommendations. ACOG recommends all pregnant people are screened for syphilis at their first prenatal visit and potentially retested at delivery if at high risk; however, it does not recommend routine screening for all people who are not pregnant. A broad mandate that requires tests to be offered to all reproductive aged women regardless of risk, even when not needed or recommended through clinical guidance, could strain public health resources, diverting them from other critical areas or from higher risk populations, and take time away from why the women sought healthcare to begin with. Efficient and more cost-effective use of limited public health resources often requires prioritizing interventions based on risk assessments and epidemiological data. Rather than a blanket mandate, we should focus on high-risk groups, improve access to voluntary testing, and invest in education and prevention might yield better outcomes in terms of both health and economics.
The California Medical Association is opposed to this bill and states that like many other bills legislating medicine, this bill offers a “one-size-fits-all approach” that does not take into consideration the many other clinical factors. Efficient and more cost-effective use of limited public health resources often requires prioritizing interventions based on risk assessments and epidemiological data. Rather than a blanket mandate, public health strategies benefit more from being targeted and nuanced, focusing on higher-risk populations and tailored interventions based on clinical guidance. - RELATED LEGISLATION. AB 2132 (Low) requires an adult patient receiving primary care services in specified health care settings, to be offered a TB risk assessment and TB screening test, if certain conditions apply. AB 2132 is pending in the Assembly Appropriations Committee.
- PREVIOUS LEGISLATION.
- AB 789 (Low), Chapter 470, Statutes of 2021, requires an adult patient who receives primary care services to be offered a hepatitis B and C screening test according to the latest recommendations from the USPSTF, and to the extent these services are covered under the patient's health insurance, unless the patient lacks capacity to consent to the test, or is being treated in the ED of a GACH.
- SB 306 (Pan), Chapter 486, Statutes of 2021, permits pharmacists to dispense a drug, without the name of an individual for whom the drug is intended, when prescribed for the sexual partner of someone who has been diagnosed with a STD; prohibits health care providers who prescribe, dispense, or furnish such a drug from being subject to, civil, criminal, or administrative penalties, as specified; requires a syphilis blood test, during the third trimester of pregnancy and at delivery, as specified; requires public and commercial health coverage of home STD test kits; and, adds rapid STD tests to existing law which permits HIV counselors to perform rapid HIV and hepatitis C tests.
REGISTERED SUPPORT / OPPOSITION:
Support
AIDS Healthcare Foundation
Opposition
American College of Obstetricians and Gynecologists District IX
California Medical Association
Analysis Prepared by: Lara Flynn / HEALTH / (916) 319-2097
Discussed in Hearing
Assembly Standing Committee on Health
Assembly Standing Committee on Health
Assembly Standing Committee on Health
Bill Author
Bill Co-Author(s):